A detailed history of Fmr LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 43,066 shares of VTYX stock, worth $87,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,066
Previous 37,123 16.01%
Holding current value
$87,854
Previous $81,000 39.51%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$1.15 - $2.52 $6,834 - $14,976
5,943 Added 16.01%
43,066 $49,000
Q4 2024

Feb 13, 2025

SELL
$1.72 - $3.12 $161,272 - $292,540
-93,763 Reduced 71.64%
37,123 $81,000
Q3 2024

Nov 13, 2024

BUY
$1.85 - $3.2 $7,129 - $12,332
3,854 Added 3.03%
130,886 $285,000
Q2 2024

Aug 13, 2024

SELL
$2.31 - $5.59 $581,170 - $1.41 Million
-251,589 Reduced 66.45%
127,032 $293,000
Q1 2024

May 13, 2024

BUY
$1.9 - $10.13 $587,362 - $3.13 Million
309,138 Added 444.91%
378,621 $2.08 Million
Q4 2023

Feb 13, 2024

SELL
$2.08 - $31.18 $17.9 Million - $268 Million
-8,608,046 Reduced 99.2%
69,483 $171,000
Q3 2023

Nov 13, 2023

BUY
$29.8 - $40.3 $3.7 Million - $5.01 Million
124,298 Added 1.45%
8,677,529 $301 Million
Q2 2023

Aug 11, 2023

BUY
$28.53 - $39.55 $27.1 Million - $37.5 Million
948,890 Added 12.48%
8,553,231 $281 Million
Q1 2023

May 11, 2023

BUY
$29.51 - $46.65 $174 Million - $276 Million
5,909,854 Added 348.77%
7,604,341 $255 Million
Q4 2022

Feb 13, 2023

SELL
$24.16 - $36.38 $4.86 Million - $7.32 Million
-201,325 Reduced 10.62%
1,694,487 $55.6 Million
Q3 2022

Nov 10, 2022

BUY
$12.64 - $38.7 $4.04 Million - $12.4 Million
319,870 Added 20.3%
1,895,812 $65.4 Million
Q2 2022

Aug 12, 2022

BUY
$11.95 - $18.75 $9.07 Million - $14.2 Million
758,903 Added 92.88%
1,575,942 $19.3 Million
Q1 2022

May 13, 2022

BUY
$10.0 - $19.98 $33,670 - $67,272
3,367 Added 0.41%
817,039 $11.1 Million
Q4 2021

Feb 14, 2022

BUY
$14.2 - $23.07 $11.6 Million - $18.8 Million
813,672 New
813,672 $16.2 Million

Others Institutions Holding VTYX

About Ventyx Biosciences, Inc.


  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $115M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.